Cisco intends to purchase the network analytics software producer, which had raised more than $110m from investors including GV and Salesforce Ventures, for a reported $1bn.

Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.

Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer is set to raise up to $96m.

Eli Lilly, EMS, Takeda and ST Pharm are in line for exits after muscle disease therapy developer Avidity filed for a $100m initial public offering.

Apple has bought Inductiv to integrate the latter's machine learning data cleanup expertise, based on Stanford, Wisconsin-Madison and Waterloo faculty innovations.

The oncology diagnostics technology provider has filed to go public in the US, with Legend Holdings and Eli Lilly set to exit through the flotation.

Appliance manufacturer Gree bought $89m of shares in an initial public offering in which the oncology therapy developer floated at the top of its range.

The Xiaomi, Intel and Samsung-backed semiconductor and silicon production services provider is valued at more than $420m and is set to float in Shanghai.

The Vietnamese e-commerce platforms have reportedly agreed to merge subject to regulatory approval, having jointly raised nearly $300m from backers including SoftBank and JD.com.

Roche has purchased Stratos Group's DNA sequencing spinoff five years after its corporate venturing subsidiary contributed to a $30m series B round.